
Caplin Point Laboratories Ltd.
Caplin Point Lab
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹130.03 Cr.
No Subsidiaries Data available
Caplin Point Laboratories is a fast growing, fully integrated Pharmaceutical company with a dominant presence in Latin America, Francophone Africa and a growing presence in the Regulated markets such as USA and EU. The company was established in 1990 to manufacture a range of ointments, creams and other external applications. The company was listed in 1994 following its Initial Public Offering (IPO), the proceeds of which were deployed in setting up a manufacturing facility at Pondicherry. Thereafter, the company expanded its product range and increased its production capacity. The company has own state of the art manufacturing facilities that cater to a complete range of finished dosage forms.
The Company focused on the emerging markets of Latin America, Caribbean, Francophone and Southern Africa and is one of the leading suppliers of Pharmaceuticals in these regions, with various product licenses across the globe. The company thrives on a unique business model of owning distribution networks, catering predominantly to the Bottom of the Pyramid, in the areas of its presence. Caplin Point maintains deep focus on innovative technologies and products, with a sizeable part of its annual earnings invested into Research & Development of safe and effective products across varied dosage forms.
Business area of the company
Caplin Point Laboratories is engaged in manufacture of pharmaceuticals formulations. It is a fast-growing Indian pharmaceutical company with global reach, having a 100% export-oriented business. The company supplies a complete range of finished dosage forms. The company operates on a unique business model which predominantly caters to emerging markets of Latin America and Africa and a growing presence in regulated markets like the USA, Canada, Australia etc.
Products
Regulated Markets
Emerging Markets
Awards and recognitions
Milestones
